Francesca Pellicano

1.8k total citations
27 papers, 992 citations indexed

About

Francesca Pellicano is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Francesca Pellicano has authored 27 papers receiving a total of 992 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 12 papers in Molecular Biology and 12 papers in Genetics. Recurrent topics in Francesca Pellicano's work include Chronic Myeloid Leukemia Treatments (19 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Acute Myeloid Leukemia Research (7 papers). Francesca Pellicano is often cited by papers focused on Chronic Myeloid Leukemia Treatments (19 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Acute Myeloid Leukemia Research (7 papers). Francesca Pellicano collaborates with scholars based in United Kingdom, United States and Italy. Francesca Pellicano's co-authors include Tessa L. Holyoake, Mhairi Copland, Lisa Hopcroft, Elaine Allan, Heather G. Jørgensen, Mary T. Scott, Tomoko Iwata, Anthony D. Whetton, Rachel E. Thomson and David Vetrie and has published in prestigious journals such as Nature, The Journal of Experimental Medicine and Blood.

In The Last Decade

Francesca Pellicano

26 papers receiving 979 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesca Pellicano United Kingdom 17 570 458 352 157 127 27 992
Agata Klejman Poland 9 237 0.4× 266 0.6× 166 0.5× 96 0.6× 90 0.7× 17 586
William Lento United States 12 281 0.5× 553 1.2× 134 0.4× 156 1.0× 14 0.1× 16 880
Susan Jones‐Bolin United States 9 339 0.6× 424 0.9× 185 0.5× 184 1.2× 14 0.1× 14 769
Sarah M. Jacobs-Helber United States 13 193 0.3× 391 0.9× 101 0.3× 253 1.6× 47 0.4× 16 782
Trevor Price United States 9 167 0.3× 340 0.7× 86 0.2× 308 2.0× 20 0.2× 21 849
Fazila Asmar Denmark 16 109 0.2× 550 1.2× 92 0.3× 116 0.7× 41 0.3× 22 763
Tom Daniel Switzerland 9 724 1.3× 937 2.0× 147 0.4× 363 2.3× 16 0.1× 16 1.2k
Niranjan Yanamandra United States 18 155 0.3× 441 1.0× 76 0.2× 265 1.7× 37 0.3× 28 823
Frank J.G. Scherpen Netherlands 14 149 0.3× 363 0.8× 103 0.3× 146 0.9× 9 0.1× 33 592
Sébastien Grosso France 14 99 0.2× 719 1.6× 73 0.2× 95 0.6× 35 0.3× 15 1.0k

Countries citing papers authored by Francesca Pellicano

Since Specialization
Citations

This map shows the geographic impact of Francesca Pellicano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Pellicano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Pellicano more than expected).

Fields of papers citing papers by Francesca Pellicano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Pellicano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Pellicano. The network helps show where Francesca Pellicano may publish in the future.

Co-authorship network of co-authors of Francesca Pellicano

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Pellicano. A scholar is included among the top collaborators of Francesca Pellicano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Pellicano. Francesca Pellicano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Dandan, Le Xuan Truong Nguyen, Fang Chen, et al.. (2021). Spred1 deficit promotes treatment resistance and transformation of chronic phase CML. Leukemia. 36(2). 492–506. 5 indexed citations
2.
Pellicano, Francesca, Lisa Hopcroft, Mary T. Scott, et al.. (2018). hsa-mir183/EGR1–mediated regulation of E2F1 is required for CML stem/progenitor cell survival. Blood. 131(14). 1532–1544. 33 indexed citations
3.
Vezzalini, Marzia, Andrea Mafficini, Luisa Tomasello, et al.. (2017). A new monoclonal antibody detects downregulation of protein tyrosine phosphatase receptor type γ in chronic myeloid leukemia patients. Journal of Hematology & Oncology. 10(1). 129–129. 29 indexed citations
4.
Scott, Mary T., Koorosh Korfi, Peter Saffrey, et al.. (2016). Epigenetic Reprogramming Sensitizes CML Stem Cells to Combined EZH2 and Tyrosine Kinase Inhibition. Cancer Discovery. 6(11). 1248–1257. 99 indexed citations
5.
Tarafdar, Anuradha, Lisa Hopcroft, Paolo Gallipoli, et al.. (2016). CML cells actively evade host immune surveillance through cytokine-mediated downregulation of MHC-II expression. Blood. 129(2). 199–208. 56 indexed citations
6.
Abraham, Sheela A., Lisa Hopcroft, Emma Carrick, et al.. (2016). Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells. Nature. 534(7607). 341–346. 165 indexed citations
7.
Sinclair, Amy, Mansi Shah, Mark E. Drotar, et al.. (2016). CXCR2 and CXCL4 regulate survival and self-renewal of hematopoietic stem/progenitor cells. Blood. 128(3). 371–383. 53 indexed citations
8.
Pellicano, Francesca, Mary T. Scott, G. Vignir Helgason, et al.. (2014). The Antiproliferative Activity of Kinase Inhibitors in Chronic Myeloid Leukemia Cells Is Mediated by FOXO Transcription Factors. Stem Cells. 32(9). 2324–2337. 80 indexed citations
9.
Aspinall-O’Dea, Mark, Andrew Pierce, Francesca Pellicano, et al.. (2014). Antibody-based detection of protein phosphorylation status to track the efficacy of novel therapies using nanogram protein quantities from stem cells and cell lines. Nature Protocols. 10(1). 149–168. 20 indexed citations
10.
Abraham, Sheela A., Lisa Hopcroft, Emma Carrick, et al.. (2013). p53 and c-Myc Are Critical Signaling Hubs That Maintain Chronic Myeloid Leukemia. Blood. 122(21). 1465–1465.
11.
Balabanov, Stefan, Caroline A. Evans, Sheela A. Abraham, et al.. (2012). Quantitative proteomics analysis of BMS ‐214662 effects on CD 34 positive cells from chronic myeloid leukaemia patients. PROTEOMICS. 13(1). 153–168. 6 indexed citations
12.
Pellicano, Francesca, Amy Sinclair, & Tessa L. Holyoake. (2011). In Search of CML Stem Cells’ Deadly Weakness. Current Hematologic Malignancy Reports. 6(2). 82–87. 14 indexed citations
13.
Pellicano, Francesca, Rachel E. Thomson, Gareth J. Inman, & Tomoko Iwata. (2010). Regulation of cell proliferation and apoptosis in neuroblastoma cells by ccp1, a FGF2 downstream gene. BMC Cancer. 10(1). 657–657. 9 indexed citations
14.
Pellicano, Francesca, Bin Zhang, Lisa Crawford, et al.. (2010). Bortezomib induces apoptosis in primitive chronic myeloid leukemia cells including LTC-IC and NOD/SCID repopulating cells. Blood. 115(11). 2241–2250. 44 indexed citations
15.
Pellicano, Francesca, Mhairi Copland, Heather G. Jørgensen, et al.. (2009). BMS-214662 induces mitochondrial apoptosis in chronic myeloid leukemia (CML) stem/progenitor cells, including CD34+38− cells, through activation of protein kinase Cβ. Blood. 114(19). 4186–4196. 39 indexed citations
16.
Bartolo, Paolo Di, Francesca Pellicano, T. Casetti, et al.. (2008). Better Postprandial Glucose Stability During Continuous Subcutaneous Infusion with Insulin Aspart Compared with Insulin Lispro in Patients with Type 1 Diabetes. Diabetes Technology & Therapeutics. 10(6). 495–498. 18 indexed citations
17.
Pellicano, Francesca & Tessa L. Holyoake. (2007). Stem cells in chronic myeloid leukaemia. Cancer Biomarkers. 3(4-5). 183–191. 3 indexed citations
18.
Thomson, Rachel E., Francesca Pellicano, & Tomoko Iwata. (2006). Fibroblast growth factor receptor 3 kinase domain mutation increases cortical progenitor proliferation via mitogen‐activated protein kinase activation. Journal of Neurochemistry. 100(6). 1565–1578. 29 indexed citations
19.
Broadgate, Suzanne, Rachel E. Thomson, Francesca Pellicano, et al.. (2005). FGFR3 regulates brain size by controlling progenitor cell proliferation and apoptosis during embryonic development. Developmental Biology. 279(1). 73–85. 66 indexed citations
20.
Pellicano, Francesca, et al.. (2005). Expression of coiled-coil protein 1, a novel gene downstream of FGF2, in the developing brain. Gene Expression Patterns. 6(3). 285–293. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Agata Klejman Breakdown of academic impact, for papers by William Lento Breakdown of academic impact, for papers by Susan Jones‐Bolin Breakdown of academic impact, for papers by Sarah M. Jacobs-Helber Breakdown of academic impact, for papers by Trevor Price Breakdown of academic impact, for papers by Fazila Asmar Breakdown of academic impact, for papers by Tom Daniel Breakdown of academic impact, for papers by Niranjan Yanamandra Breakdown of academic impact, for papers by Frank J.G. Scherpen Breakdown of academic impact, for papers by Sébastien Grosso
Rankless by CCL
2026